InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update [Financial Post (Toronto, Ontario, Canada)]
InMed Pharmaceuticals Inc. - Common Shares (INM)
Company Research
Source: Financial Post
VANCOUVER, British Columbia, Sept. 24, 2021 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today reported financial results for the fiscal year ended June 30, 2021. Conference Call & Webcast: Friday, September 24, 2021, at 8:00 AM Pacific Time, 11:00 AM Eastern Time US/CANADA Participant Toll-Free Dial-In Number: +1 (855) 605-1745 US/CANADA Participant International Dial-In Number: +1 (914) 987-7959 Conference ID: 9373618 Webcast: https://edge.media-server.com/mmc/p/ny89uo2r *Webcast replay available for 90 days) The Company's full financial statements and related MD&A for the fiscal year ended June 30, 2021, are available at www.inmedpharma.com www.sedar.com and at www.sec.gov Eric A. Adams, InMed CEO, states, “In the final quarter of our of fiscal year 2021, as well as throughout the year, we made important progress in corporate development, pharma
Show less
Read more
Impact Snapshot
Event Time:
INM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INM alerts
High impacting InMed Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
INM
News
- InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance [Yahoo! Finance]Yahoo! Finance
- InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET [Yahoo! Finance]Yahoo! Finance
- InMed Pharmaceuticals Provides Business Update and Milestones for 2024 [Yahoo! Finance]Yahoo! Finance
INM
Sec Filings
- 3/20/24 - Form 8-K
- 3/5/24 - Form 4
- 3/5/24 - Form 4
- INM's page on the SEC website